Haleon PLC closed 6.63% below its 52-week high of £4.01, which the company reached on September 18th.

(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and ...

Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...

Haleon PLC closed 5.73% below its 52-week high of £4.01, which the company reached on September 18th.

Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...

Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...

Deal priced at a 2.8% discount to the prior closing level Shares of Haleon rose on Wednesday after the stake deal Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in ...

Pfizer will sell shares worth £2.50 billion (€2.96 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner JPMorgan has said.

Pfizer has sold 700 million shares in British consumer-healthcare business Haleon for 2.50 billion pounds, equivalent to US$3.05 billion, it said in a statement. The U.S. drugmaker said Wednesday ...